Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

scientific article

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHM355
P3181OpenCitations bibliographic resource ID714346
P698PubMed publication ID17951287
P5875ResearchGate publication ID279958122

P50authorHarvey WhiteQ1587897
Philippe Gabriel StegQ16027739
Hugo A. KatusQ27929168
Kenneth DicksteinQ43248428
Michał TenderaQ48860774
Erik Magnus OhmanQ60697402
L Kristin NewbyQ77796327
A. John CammQ110902795
P2093author name stringS. G. Priori
J. Morais
R. De Caterina
R. Harrington
A. Vahanian
P. Pais
K. M. Fox
P. A. Poole-Wilson
G. A. Beller
A. S. Jaffe
B. F. Uretsky
W. B. Gibler
D. O. Williams
J. S. Alpert
C. W. Hamm
P. W. Armstrong
A. N. Parkhomenko
U. Sechtem
M. Lim
C. Funck-Brentano
G. Filippatos
J. J. Bax
K. McGregor
M. Tubaro
P. Widimsky
S. D. Kristensen
V. Dean
R. Underwood
D. Morrow
M. L. Simoons
K. Thygesen
F. Fernandez-Aviles
E. M. Antman
D. Goff
K. A. Fox
T. B. Ferguson
G. N. Levine
W. Wijns
L.-M. Voipio-Pulkki
E. E. Van Der Wall
S. Silber
B. Chaitman
R. Bonow
F. S. Apple
S. Mendis
J. L. Zamorano
D. Dudek
E. P. Gurfinkel
H. Hod
I. Hellemans
J. Ravkilde
J.-L. Lopez-Sendon
J.-P. Bassand
J.-R. Zhu
L. C. Wallentin
M. A. Martinez-Rios
M. Dellborg
M. Galvani
N. Al-Attar
P. M. Clemmensen
P. Porela
S. Brener
S. Steinhubl
P433issue20
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
P304page(s)2525-2538
P577publication date2007-09-07
P1433published inEuropean Heart JournalQ2286839
P1476titleUniversal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
P478volume28

Reverse relations

cites work (P2860)
Q95417637Q95417637
Q379538852011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi
Q9301703324-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity
Q57037490A Priori–Defined Dietary Patterns Are Associated with Reduced Risk of Stroke in a Large Italian Cohort
Q22252541A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction
Q33638409A case report of spinal dural arteriovenous fistula: origins, determinants, and consequences of abnormal vascular malformations
Q54367778A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population.
Q64079704A circulating miRNA signature for early diagnosis of acute kidney injury following acute myocardial infarction
Q33824669A comparison of off-pump and on-pump coronary bypass surgery in patients with low EuroSCORE
Q46059674A multicentre analysis of troponin use in clinical practice
Q35052889A new generation of biomarkers tests of myocardial necrosis: the real quality a physician can get from the laboratory
Q40002380A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score.
Q39654691A possible association between space weather conditions and the risk of acute coronary syndrome in patients with diabetes and the metabolic syndrome
Q40107092A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases
Q39363411A rapid, direct, quantitative, and label-free detector of cardiac biomarker troponin T using near-infrared fluorescent single-walled carbon nanotube sensors.
Q37874799A review of interventions aimed at reducing pre-hospital delay time in acute coronary syndrome: what has worked and why?
Q38466780A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease
Q38657532A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events.
Q42966181A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes
Q37140988ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction.
Q39910247Accuracy of EASI 12-lead ECGs in monitoring ST-segment and J-point by nurses in the Coronary Care Units
Q52381871Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in italy.
Q43226804Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis
Q34785177Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs
Q43103704Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response
Q43778043Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events
Q51373718Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes.
Q54069247Acute myocardial infarction
Q34272594Acute myocardial infarction associated to DPP-4 inhibitors
Q48401055Acute myocardial infarction complicated by shock: outcome analysis based on initial electrocardiogram
Q34628066Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK.
Q40208516Acute-phase proteins and oxidative stress in patients undergoing coronary artery bypass graft: comparison of cardioplegia strategy
Q86206726Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
Q24187926Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
Q24202298Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
Q34111144Adenosine diphosphate–induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events
Q37463255Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome
Q40495177Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction. Treatment regimens in German chest pain units
Q44769587Age-specific 99th percentile cutoff of high-sensitivity cardiac troponin T for early prediction of non-ST-segment elevation myocardial infarction (NSTEMI) in middle-aged patients.
Q95841288Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration
Q36669772An algorithm that identifies coronary and heart failure events in the electronic health record
Q58897839An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports
Q58897834An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports
Q43180190An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
Q40160496An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.
Q48163488An investigation of the independent risk factors that differentiate gout from pseudogout in patients with crystal-induced acute arthritis: a cross-sectional study.
Q42662070An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy
Q48191598An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
Q85167019Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population
Q35670653Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction
Q33738712Anemia in critical illness: insights into etiology, consequences, and management
Q34508351Animal models of cardiac disease and stem cell therapy
Q39323874Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review
Q83163607Anxiety trait in patients with stress-induced cardiomyopathy: a case-control study
Q59783098Análisis crítico y propuestas de mejora de los sistemas de información sobre enfermedades cardiovasculares en España
Q42270434Aortic dissection with concomitant acute myocardial infarction: From diagnosis to management
Q34295833Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells
Q42957452Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population
Q38264294Application of microRNAs in diagnosis and treatment of cardiovascular disease
Q54594382Artificial-epitope mapping for CK-MB assay.
Q34561285Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology
Q37685626Assessment of the management of acute myocardial infarction patients and their outcomes at the Nairobi Hospital from January 2007 to June 2009.
Q36633686Association Between Smoking and Physician-Diagnosed Stroke and Myocardial Infarction in Male Adults in Korea
Q36675776Association between frailty, cerebral oxygenation and adverse post-operative outcomes in elderly patients undergoing non-cardiac surgery: An observational pilot study
Q50955829Association between periodontitis and acute myocardial infarction: a case-control study of a nondiabetic population.
Q36283703Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography
Q36058977Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population.
Q58573294Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarction
Q33970602Atrial fibrillation and the risk of myocardial infarction
Q45839045Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection.
Q51503137Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
Q41281344B-type natriuretic peptide predicts long-term prognosis in a cohort of critically ill patients
Q42710195Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity
Q45964336Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
Q83426306Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy
Q90291256Bone marrow mesenchymal stem cell-derived exosomes protect against myocardial infarction by promoting autophagy
Q83217859CT angiography; no collateral damage
Q53374687CT angiography; useful in non-selected outpatients?
Q42856734CT perfusion angiography; beware of artifacts!
Q34649009CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population
Q37473732Can cardiac computed tomography predict cardiovascular events in asymptomatic type-2 diabetics?: results of a long term follow-up
Q26853640Can lipoprotein-associated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome?
Q38216215Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX).
Q52985157Cardiac CT assessment of left ventricular mass in mid-diastasis and its prognostic value.
Q92179634Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting
Q64245221Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction
Q35856435Cardiac biomarkers in the intensive care unit
Q51794706Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality.
Q84597610Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy
Q33810087Cardiac troponin and cerebral herniation in acute intracerebral hemorrhage
Q47671109Cardiac troponins: from myocardial infarction to chronic disease.
Q38508938Cardiotoxicity due to Chemotherapy: the Role of Biomarkers
Q40534054Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience
Q37424605Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?
Q36768477Carotid intima-media thickness in young survivors of acute myocardial infarction
Q55392780Case fatality ratios for serious emergency conditions in the Republic of Ireland: a longitudinal investigation of trends over the period 2002-2014 using joinpoint analysis.
Q38869886Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality
Q26765916Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration
Q52643133Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Q40033812Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997-2010.
Q57101333Characteristics and management of acute ST-segment elevation myocardial infarctions occurring in ski resorts in the French Alps: Impact of an acute coronary care network
Q37473142Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction
Q57477200Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study
Q35290689Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction
Q33672818Clinical characteristics and outcomes of patients with myocarditis mimicking ST-segment elevation myocardial infarction: Analysis of a case series
Q47926476Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy.
Q34204883Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
Q37454956Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland
Q36540406Clinical features of myocardial infarction and myocarditis in young adults: a retrospective study.
Q34014530Clinical implication of coronary tortuosity in patients with coronary artery disease
Q36644752Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome
Q38102533Clinical implications of the Third Universal Definition of Myocardial Infarction
Q64974769Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome.
Q35731045Cocaine use does not affect mean platelet volume
Q36301931Cohort Profile: the Corogene study
Q49169613Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department.
Q28546788Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent
Q43565621Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial
Q37202126Comparative value of simple inflammatory markers in the prediction of left ventricular systolic dysfunction in postacute coronary syndrome patients.
Q31138335Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage
Q36555021Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction
Q36578419Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes
Q45359342Comparison of cardiogoniometry and ECG at rest versus myocardial perfusion scintigraphy.
Q35331615Comparison of clinical outcomes of hydrophilic and lipophilic statins in patients with acute myocardial infarction
Q89119253Comparison of clinical risk scores for triaging high-risk chest pain patients at the emergency department
Q28641211Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries
Q58088773Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes
Q34179703Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction
Q35131648Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients.
Q37141021Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients
Q50852806Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and
Q36961770Comprehensive quality of discharge summaries at an academic medical center
Q27315149Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiography
Q26829251Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
Q37221845Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
Q53733243Continuous ECG Monitoring in Patients With Acute Coronary Syndrome or Heart Failure: EASI Versus Gold Standard.
Q37871924Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
Q37682501Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization
Q38136336Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs
Q55002418Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome.
Q38220601Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?
Q35861587Coronary dominance and prognosis in patients undergoing coronary computed tomographic angiography: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) registry
Q38631031Coronary dominance and prognosis in patients with chronic total occlusion treated with percutaneous coronary intervention.
Q27026525Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Q34781673Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting
Q35670489Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis
Q37377798Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort
Q38028866Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea.
Q38933669Daily Lowest Hemoglobin and Risk of Organ Dysfunctions in Critically Ill Patients
Q34304750Daylight savings time and myocardial infarction
Q64891127Derivation and validation of a prediction score for acute kidney injury secondary to acute myocardial infarction in Chinese patients.
Q36727235Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study).
Q50065243Detecting myocardial infarction type 2: targetting the right patients
Q36042620Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction
Q35739989Developments in the invasive diagnostic-therapeutic cascade of women and men with acute coronary syndromes from 2005 to 2011: a nationwide cohort study
Q64289545Diagnosis and Management of an Inferior ST-elevation Myocardial Infarction: A Simulation Scenario
Q35940654Diagnosis of Coronary Heart Diseases Using Gene Expression Profiling; Stable Coronary Artery Disease, Cardiac Ischemia with and without Myocardial Necrosis
Q37291917Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.
Q33773201Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome
Q26746722Diagnostic algorithms for acute coronary syndrome-is one better than another?
Q33613089Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study
Q87146986Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain study
Q37425286Diastolic function is a strong predictor of mortality in patients with chronic kidney disease.
Q53491332Differences in ward-to-cath lab systolic blood pressure predicts long-term adverse outcomes after drug-eluting stent implantation.
Q41954032Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome
Q42679244Differential expression of B-type natriuretic peptide between left and right ventricles, with particular regard to sudden cardiac death
Q43953904Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry
Q44656194Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems
Q47903182Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not.
Q59208809Does Continuous ST-Segment Monitoring Add Prognostic Information to the TIMI, PURSUIT, and GRACE Risk Scores?
Q50668373Does longitudinal strain predict left ventricular remodeling after myocardial infarction?
Q22242892ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)
Q55037705Early and long-term outcomes of complete revascularization with percutaneous coronary intervention in patients with multivessel coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.
Q50217429Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin
Q40771637Early invasive versus early conservative strategy in non-ST-elevation acute coronary syndrome: An outcome research study.
Q36797852Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Q34541855Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS)
Q44007391Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Q34207158Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands
Q41188685Effect of smoking status on coronary artery disease among Chinese post-menopausal women
Q43722133Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis
Q47988864Effectiveness of a cardiac surgery-specific transfusion protocol.
Q48554961Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal Glucose Tolerance.
Q92241544Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Q44876601Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction.
Q43128990Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
Q37151370Efficacy of coronary revascularization in patients with acute chest pain managed in a chest pain unit
Q37856195Egg consumption and risk of cardiovascular disease in the SUN Project
Q83568984Electrocardiographic findings and myocardial damage in acute myocarditis detected by cardiac magnetic resonance
Q43294342Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients
Q33166211Elevated Troponin I in the Absence of Coronary Artery Disease: A Case Report With Review of Literature
Q35674364Endothelial Injury Associated with Cold or Warm Blood Cardioplegia during Coronary Artery Bypass Graft Surgery
Q96303042Enhancement of label-free biosensing of cardiac troponin I
Q35005369Estimated Glomerular Filtration Rate in Short-Risk Stratification in Acute Myocardial Infarction.
Q37291921Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries
Q85213714European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes
Q45173223Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up.
Q37755114Evaluating the role of elevated levels of troponin in acute ischemic stroke
Q44506632Evaluation of analytical performance of the Pathfast cardiac troponin I.
Q48567121Evaluation of beat-to-beat ventricular repolarization lability from standard 12-lead ECG during acute myocardial ischemia
Q36270066Evaluation of early interventional treatment opportunity of the elderly & high-risk patients with non-ST segment elevation acute myocardial infarction
Q51837358Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
Q57065396Factors associated with delayed hospital arrival among patients with acute myocardial infarction: a cross-sectional study in Greece
Q36134566Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction.
Q47712900Female gender doubles pre-hospital delay times for patients experiencing ST segment elevation myocardial infarction in Saudi Arabia
Q42922467Fingertip digital thermal monitoring: a fingerprint for cardiovascular disease?
Q38572086Fluid Restriction During Pancreaticoduodenectomy: Is It Effective in Reducing Postoperative Complications?
Q42870481Fractional flow reserve application in everyday practice: adherence to clinical recommendations
Q40793052Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients.
Q46800270Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting
Q39821542Frontline diagnostic evaluation of patients suspected of angina by coronary computed tomography reduces downstream resource utilization when compared to conventional ischemia testing.
Q38647581GDF-15 predicts cardiovascular events in acute chest pain patients.
Q47164229Gap in gender parity: gender disparities in incidence and clinical impact of chronic total occlusion in non-infarct artery in patients with non-ST-segment elevation myocardial infarction and multivessel coronary artery disease
Q34347046Gated myocardial SPECT imaging; true additional value in AMI?
Q36306613Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
Q36686301Gender differences in association between metabolic syndrome and carotid intima media thickness
Q53061328Gender differences in correlates of troponin assay in diagnosis of myocardial infarction.
Q54617131Gender differences in serum CK-MB mass levels in healthy Brazilian subjects.
Q47120408Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland
Q38390243Gender-specific uncertainties in the diagnosis of acute coronary syndrome.
Q35824246Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population
Q34318279Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
Q48453082Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study
Q85066486Growth differentiation factor 15 in different stages of heart failure: potential screening implications
Q43284567Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery
Q57245270Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca
Q57243422Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST
Q53363035Heart attack guidance for physicians: When to suspect, how to diagnose, what to do?
Q40390419Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010.
Q36426643Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain
Q36997386Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure
Q51330574Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Q44822548Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome
Q86971780Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction
Q36205878High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention
Q84538472High sensitivity troponin in chest pain and acute coronary syndromes. A step forward?
Q85212685High sensitivity troponins and better patient care
Q58603279High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study
Q34674934High-resolution 12-lead electrocardiograms of on-duty professional firefighters: a pilot feasibility study
Q48540294High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
Q35648924High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy
Q36974321High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice?
Q37036975High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study
Q37926596High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department
Q48149378Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism
Q36828022Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study
Q39115994How should clinicians interpret cardiac troponin values in patients with ESRD?
Q58314226How to use high-sensitivity cardiac troponins in acute cardiac care
Q39225029Hyoscine-N-butyl-bromide-induced hypotension and myocardial ischemia
Q59652458Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac m
Q64101045IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
Q46136203Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years
Q37594513Impact of High Risk for Obstructive Sleep Apnea on Survival after Acute Coronary Syndrome: Insights from the ERICO Registry
Q35739774Impact of Intercellular Adhesion Molecule-1 Genetic Polymorphisms on Coronary Artery Disease Susceptibility in Taiwanese Subjects
Q52603881Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
Q44828860Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes.
Q44936093Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention
Q33975575Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
Q33671080Impact of perioperative acute ischemic stroke on the outcomes of noncardiac and nonvascular surgery: a single centre prospective study
Q44774947Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme.
Q55071502Impact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention.
Q35842008Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study
Q35128758Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery
Q43545029Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease
Q50849590Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited.
Q46380285Implications of the universal definition of myocardial infarction
Q60722947Implicações prognósticas da pressão telediastólica do ventrículo esquerdo nas síndromes coronárias agudas com fracção de ejecção maior ou igual a 40%
Q38025446Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel
Q50094174Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
Q35822223Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country
Q36053300Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study
Q50577959Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012).
Q64066315Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
Q40494505Increased accuracy in computed tomography coronary angiography; a new body surface area adapted protocol
Q84912378Increased aortic stiffness can predict perioperative cardiovascular outcomes in patients undergoing noncardiac, nonvascular surgery
Q46090017Increased ischaemia modified albumin following coronary artery bypass grafting
Q35107777Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
Q35121147Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFI
Q49609058Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals.
Q36537308Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus
Q34341707Incremental prognostic value of left ventricular function analysis over non-invasive coronary angiography with multidetector computed tomography
Q40362953Induction of a chronic myocardial infarction in the laboratory animal - experimental model
Q37414864Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study.
Q84153015Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study
Q36549998Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
Q37279845Inflammatory Cytokines as Risk Factors for Mortality After Acute Cardiac Events
Q51371087Influence of abnormal fasting plasma glucose on left ventricular function in older patients with acute myocardial infarction.
Q53256527Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography.
Q34632431Interaction of type 2 diabetes mellitus with chromosome 9p21 rs10757274 polymorphism on the risk of myocardial infarction: a case-control study in Chinese population
Q55470760Interleukin-6 contributes to myocardial damage in pregnant rats with reduced uterine perfusion pressure.
Q49913486Interphysician agreement on subclassification of myocardial infarction
Q58230148Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention
Q30467896Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes
Q36307110Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study
Q36099107Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery
Q35681010Kinetics of plasma microRNA-499 expression in acute myocardial infarction
Q38651014Lack of association between cystatin C and different coronary atherosclerotic manifestations.
Q36656914Lack of cardioprotection by single-dose magnesium prophylaxis on isoprenaline-induced myocardial infarction in adult Wistar rats
Q37323623Lack of consensus in biomarker measurement to diagnose PCI-related myocardial infarction
Q92947255Long noncoding RNA MALAT1 promotes cardiomyocyte apoptosis after myocardial infarction via targeting miR-144-3p
Q50019585Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry
Q47317898Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial.
Q40050071Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes
Q36102162Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population
Q53141320MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.
Q48167674MMP1 and MMP3 gene polymorphisms in patients with acute coronary syndromes
Q41896943Magnetic resonance imaging characterization of circumferential and longitudinal strain under various coronary interventions in swine
Q37606146Management of ST-segment elevation myocardial infarction in predominantly rural central China: A retrospective observational study
Q22242896Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
Q37040319Measurement of cardiac troponins to detect myocardial infarction using high-sensitivity assays: South African guidelines.
Q36331410Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge.
Q47917702Mediterranean diet and prognosis of first-diagnosed Acute Coronary Syndrome patients according to heart failure phenotype: Hellenic Heart Failure Study
Q46374324Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction
Q35149077Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction
Q45370584Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease
Q37496035Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADS
Q47979579Mid-term outcomes of consecutive 998 cases of coronary atherectomy in contemporary clinical practice.
Q35936345Mild functional ischemic mitral regurgitation following acute coronary syndrome: a retrospective study
Q45990491Minor myocardial damage during percutaneous coronary intervention does not affect long-term prognosis.
Q51772665Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study.
Q38443781Modification to the injection needle to a screw needle improves effective cell delivery in acute myocardial infarction
Q43520766Modified TIMI risk score cannot be used to identify low-risk chest pain in the emergency department: a multicentre validation study
Q41564278Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients
Q36595291Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention
Q34962673Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition
Q55117051Myocardial infarction and alcohol consumption: A case-control study.
Q35827555Myocardial infarction in patients over 90 years of age.
Q35806730Myocardial infarction in the elderly
Q37087148Myocardial infarction with normal coronary arteries: a case report and review of the literature
Q87878929NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department
Q38034812Nanomedicine in cardiovascular therapy: recent advancements
Q34160755Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study
Q34029108Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people
Q42122643Nitrate-induced paradoxical ischemia predicts adverse outcomes in elderly patients with healed myocardial infarcts
Q59329014Nocturnal respiratory rate as a predictor of mortality in patients with acute coronary syndrome
Q45252930Non-significant left main disease; truly non-significant?
Q57481611Nonspecific electrocardiographic abnormalities are associated with increased length of stay and adverse cardiac outcomes in prehospital chest pain
Q34804612Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
Q58812220Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes
Q87103170Observational Study of Chinese Medicine Syndrome Distribution in Patients with Acute Myocardial Infarction and Its Impact on Prognosis
Q26822387Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!
Q44187961Occupation- and age-related differences in work absence due to frequent cardiovascular diseases using essential hypertension and acute myocardial infarction as examples
Q43241028Off-pump coronary surgery causes immediate release of myocardial damage markers
Q35911633One-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study
Q30487537Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine
Q35684923Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction
Q44799286Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction
Q35926521Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
Q36168222Outcome of cardiac surgery in patients with low preoperative ejection fraction.
Q35179910Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014.
Q37291929Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI).
Q50864248Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b
Q47729211Outcomes of direct stenting in patients with ST-elevated myocardial infarction
Q37077532Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
Q34083836Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?
Q35901123PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
Q39521563Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow
Q47256572Panoramic ECG display versus conventional ECG: ischaemia detection by critical care nurses
Q38626782Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
Q58565462Percutaneous coronary intervention in patients with acute coronary syndrome in Chinese Military Hospitals, 2011-2014: a retrospective observational study of a national registry
Q35989825Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry.
Q34280264Performance of the high-sensitivity troponin assay in diagnosing acute myocardial infarction: systematic review and meta-analysis
Q34147112Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.
Q42028649Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice
Q22241918Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
Q53326948Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Q37434061Perspective on the clinical application of troponin in heart failure and states of cardiac injury
Q46162060Pharmacological stress: a useful exercise?
Q84983360Placental Growth Factor as Short-Term Predicting Biomarker in Acute Coronary Syndrome Patients with Non-ST Elevation Myocardial Infarction
Q45899768Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome.
Q38667602Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial
Q37742114Point-of-care testing in critical care: the clinician's point of view
Q34499457Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach
Q34551196Possible regulatory roles of promoter g-quadruplexes in cardiac function-related genes - human TnIc as a model.
Q35794559Post-Acute Coronary Syndrome Alcohol Abuse: Prospective Evaluation in the ERICO Study
Q30410183Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference
Q37641320Prasugrel: a critical comparison with clopidogrel.
Q37579188Prasugrel: a review of its use in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Q36017226Pre-hospital delay in patients with first time myocardial infarction: an observational study in a northern Swedish population
Q40630060Preclinical fibrinolysis in patients with ST-segment elevation myocardial infarction in a rural region
Q51814247Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging.
Q33552596Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.
Q51504036Predictive value of preoperative electrocardiography for perioperative cardiovascular outcomes in patients undergoing noncardiac, nonvascular surgery.
Q51826589Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress.
Q36392124Predictors of Delay in Seeking Health Care among Myocardial Infarction Patients, Minia District, Egypt
Q35674008Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins.
Q46077941Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience
Q35834663Prehospital 12-lead ST-segment monitoring improves the early diagnosis of acute coronary syndrome
Q37050300Prehospital electrocardiographic manifestations of acute myocardial ischemia independently predict adverse hospital outcomes
Q40219998Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry
Q40401637Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypass.
Q40704357Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Q86476754Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis
Q30976231Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort
Q48693596Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels
Q48103275Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry.
Q35644244Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?
Q45212848Prognosis of Vascular Surgery Patients Using a Quantitative Assessment of Troponin T Release: Is the Crystal Ball still Clear?
Q55278810Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome☆.
Q40873832Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
Q38084414Prognostic relevance of PCI-related myocardial infarction.
Q37090512Prognostic value of circulating chromogranin A levels in acute coronary syndromes
Q53172520Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography.
Q53109764Prognostic value of dual-source multidetector computed tomography coronary angiography in patients with stent implantation.
Q43673479Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome.
Q53668508Progressively heterogeneous mismatch of regional oxygen delivery to consumption during graded coronary stenosis in pig left ventricle.
Q55053682Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).
Q38821710Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study
Q37798014Proteomic biomarkers for diagnosis in acute myocardial infarction.
Q37333171Quality of discharge practices and patient understanding at an academic medical center
Q89144385Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review
Q89793591Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV
Q50096658Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial
Q48092260Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
Q33737783Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a population-based cohort study in the Netherlands
Q90670056Real-Time in Vivo Photoacoustic Imaging in the Assessment of Myocardial Dynamics in Murine Model of Myocardial Ischemia
Q34364949Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
Q53330994Recanalization of chronic total coronary occlusions--high success rate despite a restrictive use of the retrograde approach.
Q35626702Recent advances in the diagnosis and treatment of acute myocardial infarction
Q58314269Recommendations for the use of cardiac troponin measurement in acute cardiac care
Q36439280Recurrent intraoperative silent ST depression responding to phenylephrine.
Q42361221Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases.
Q92604593Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax
Q39313104Regional ejection fraction and regional area strain for left ventricular function assessment in male patients after first-time myocardial infarction
Q34621168Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
Q55405593Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study.
Q33837952Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus
Q37292090Relationship of levels of Vitamin D with flow-mediated dilatation of brachial artery in patients of myocardial infarction and healthy control: A case-control study
Q44070722Reliable exclusion of acute coronary syndrome among hospitalized patients with elevated troponin
Q37231841Repolarization Heterogeneity of Magnetocardiography Predicts Long-Term Prognosis in Patients with Acute Myocardial Infarction
Q50450876Republished: clinical implications of the third universal definition of myocardial infarction.
Q37448924Review of the treatment of acute coronary syndrome in elderly patients
Q38373055Review on cardiovascular risk prediction
Q92133268Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice
Q92889526Right ventricular dysfunction and associated factors in patients after coronary artery bypass grafting
Q58919482Right ventricular function predicts cardiovascular events in outpatients with stable cardiovascular diseases: preliminary results
Q36649949Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis
Q89983727Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery
Q40540721Role of Akt/protein kinase B in the activity of transcriptional coactivator p300.
Q28253329Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial
Q42366803Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD)
Q48122977Role of residual acute stent malapposition in percutaneous coronary interventions
Q47679974ST Depression, No ST Change, or ST Elevation in Inferior Derivations: Which Has the Worst Outcomes in Acute Anterior Myocardial Infarction
Q38595403ST-elevation myocardial infarction following systemic inflammatory response syndrome
Q85246984ST-elevation myocardial infarction in octogerians
Q35195966ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data
Q64231843Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
Q38894581Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial
Q40021275Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
Q35130613Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study
Q34451008Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality
Q45278231Serial high-sensitivity troponin measurements for the rapid exclusion of acute myocardial infarction in low-risk patients
Q39832237Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy
Q50582259Serum cardiac troponin T in asphyxiated term neonates delivered at two teaching hospitals in lagos, Nigeria.
Q43050348Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: the Hellenic Heart Failure Study
Q36318249Serum relaxin levels as a novel biomarker for detection of acute myocardial infarction
Q52677069Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis.
Q44984251Should we improve the management of NSTEMI? Results from the population-based "acute myocardial infarction in Florence 2" (AMI-Florence 2) registry
Q33741680Significance of Platelet Volume Indices in STEMI Patients: A Case-Control Study
Q58814886Sinus Rhythm ECG Criteria Associated with Basal-Lateral Ventricular Tachycardia Substrate in Patients with Nonischemic Cardiomyopathy
Q52886547Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a).
Q26828732Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention
Q37830185Spontaneous retrograde dissection of ascending aorta from descending thoracic aorta--a case review
Q36941995Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
Q86944045Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitable
Q24193862Statins for acute coronary syndrome
Q24236697Statins for acute coronary syndrome
Q34729472Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.
Q53362662Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
Q34909801Study of serum sodium and potassium in acute myocardial infarction
Q37236462Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study
Q35119321Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population
Q33705509Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study
Q36983754Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway
Q55455435Synthesis and Characterization of Injectable Hydrogels with Varying Collagen⁻Chitosan⁻Thymosin β4 Composition for Myocardial Infarction Therapy.
Q41388982T-Wave Alternans Is Linked to Microvascular Obstruction and to Recurrent Coronary Ischemia After Myocardial Infarction
Q38187499Takotsubo cardiomyopathy: how much do we know of this syndrome in children and young adults?
Q37445883Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients
Q60920257Tegafur deteriorates established cardiovascular atherosclerosis in colon cancer: A case report and review of the literature
Q92143395Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study
Q27007476The "smoker's paradox" in patients with acute coronary syndrome: a systematic review
Q64987012The Association between Arterial Oxygen Tension, Hemoglobin Concentration, and Mortality in Mechanically Ventilated Critically Ill Patients.
Q37704006The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia
Q40115007The Glider registry.
Q89683138The Impact of the Circadian Genes CLOCK and ARNTL on Myocardial Infarction
Q51541681The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation.
Q58819391The Significance of Heart Rate Turbulence in Predicting Major Cardiovascular Events in Patients after Myocardial Infarction Treated Invasively
Q92274408The Trend in Incidence and Case-fatality of Hospitalized Acute Myocardial Infarction Patients in Korea, 2007 to 2016
Q30858405The adverse association of diabetes with risk of first acute myocardial infarction is modified by physical activity and body mass index: prospective data from the HUNT Study, Norway.
Q47929667The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction
Q28743287The challenge of triaging chest pain patients: the bernese university hospital experience
Q37326736The clinical impact of the universal diagnosis of myocardial infarction
Q34973148The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort study
Q35786724The effect of changing diagnostic algorithms on acute myocardial infarction rates
Q55105375The effect of periodontal therapy on neopterin and vascular cell adhesion molecule-1 levels in chronic periodontitis patients with and without acute myocardial infarction: a case-control study.
Q45172938The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial
Q42013589The effects of preceding exercise on myocardial damage in rats
Q54383406The effects of running a 308 km ultra-marathon on cardiac markers.
Q34640836The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery
Q38053481The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.
Q30397739The evolving epidemiology of acute coronary syndromes
Q46150148The impact of modern noninvasive cardiac imaging on coronary intervention rates
Q37980369The influence of heparin resistance on postoperative complications in patients undergoing coronary surgery
Q64065962The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction
Q44452071The myocardium supplied by a chronic total occlusion is a persistently ischemic zone.
Q38192684The mystifying nomenclature of cardiac troponin immunoassays
Q35599975The paradox of the 21st century - is there really an epidemic of most common killers?
Q38788956The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin
Q36839334The prognostic significance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndrome
Q42152808The prospect of serum magnesium and an electrolyte panel as an adjuvant cardiac biomarker in the management of acute myocardial infarction
Q64096520The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat
Q44799995The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX Score
Q53473296The relationship between revascularization extent and the long-term prognosis of patients with stable angina pectoris and three-vessel disease treated by percutaneous coronary intervention in the era of drug-eluting stents.
Q38678293The role of GST polymorphism in reperfusion induced oxidative stress, inflammatory responses and clinical complications after surgical and percutaneous coronary intervention
Q47130496The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome
Q37815453The role of cardiac electrophysiology in myocardial regenerative stem cell therapy
Q48264224The role of religious faith, spirituality and existential considerations among heart patients in a secular society: relation to depressive symptoms 6 months post acute coronary syndrome
Q35667272The rs12526453 Polymorphism in an Intron of the PHACTR1 Gene and Its Association with 5-Year Mortality of Patients with Myocardial Infarction
Q39734002The universal 2012 definition of myocardial infarction compared to the 2007 definition
Q34295914Third universal definition of myocardial infarction
Q57314061Third universal definition of myocardial infarction
Q36474491Thirty-day rehospitalizations after acute myocardial infarction: a cohort study
Q38049324Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays
Q33922443Transient ischemic attack: definition, diagnosis, and risk stratification
Q61671340Tratamiento extrahospitalario y en Urgencias del síndrome coronario agudo con elevación persistente del segmento ST
Q47960202Treatment of patients with myocardial infarction depends on history of cancer
Q92792135Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction
Q37463805Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment
Q59684149Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation
Q24630238Troponin elevation in conditions other than acute coronary syndromes
Q37822227Troponin elevation in coronary vs. non-coronary disease
Q28269814Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
Q37323094Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting
Q37289429Troponin revisited 2008: assay performance
Q36282559Troponin: think before you request one
Q82300584Troponins and high-sensitivity troponins as markers of necrosis in CAD and heart failure
Q46396768Type 2 myocardial infarction in clinical practice
Q41598744Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies
Q35083354Type-II myocardial infarction--patient characteristics, management and outcomes
Q38209902Universal MI definition update for cardiovascular disease
Q46583094Unprotected left main coronary artery disease after revascularization : effect of diabetes on patient outcomes
Q86517375Unrecognised myocardial infarction in patients with schizophrenia
Q34561430Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide.
Q58919752Update on the Universal Definition of Acute Myocardial Infarction in the Light of New Data
Q33695847Updated electrocardiographic classification of acute coronary syndromes
Q83204612Uric acid in the early risk stratification of ST-elevation myocardial infarction
Q39282279Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease
Q51767834Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.
Q42687692Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Q34769171Use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study
Q41548739Use of the anterior-posterior chest diameter in CT: reduction in radiation dose?
Q54496682Validation of the Vancouver Chest Pain Rule: a prospective cohort study.
Q38441999Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012.
Q92305993Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction
Q90394825Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis
Q24234883Vasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary intervention
Q36738245Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome
Q45180417Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
Q36324183Vulnerabilities to Temperature Effects on Acute Myocardial Infarction Hospital Admissions in South Korea
Q53822441Weather and risk of ST-elevation myocardial infarction revisited: Impact on young women.
Q41904786Welcome to the ESC journal family
Q34624212World Health Organization definition of myocardial infarction: 2008-09 revision
Q24635956Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
Q41559941Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial
Q51132112[Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only].
Q83474563[Cardiac biomarkers in the critically ill]
Q83695863[Cardiogenic shock]
Q86312717[Cardiogenic shock]
Q50868028[Interaction between heart and brain in sudden cardiac death].
Q81721527[Interventional therapy of acute myocardial infarction]
Q83189216[STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?]
Q83250042[Update on ischemic heart disease]

Search more.